Prescription drug · ANDA
Methylergonovine Maleate NDC 51662-1668
Methylergonovine maleate .2 mg/mL · Injection, Solution · Intramuscular, Intravenous · HF Acquisition Co. LLC. DBA HealthFirst
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51662-1668-1 | 51662166801 | 1 mL in 1 VIAL (51662-1668-1)Marketed from Jun 21, 2010 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methylergonovine Maleate
- Generic name (nonproprietary)
- methylergonovine maleate
- Active ingredients
- Methylergonovine maleate — .2 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090193
- Marketing start
- Listing expires
- Other FDA classes
- Ergolines (Chemical structure)
- Identifiers
- Product ID 51662-1668_4ddcdfff-1469-bff0-e063-6294a90a5480SPL ID 4ddcdfff-1469-bff0-e063-6294a90a5480SPL set ID 4ddcdfff-1468-bff0-e063-6294a90a5480RxCUI 996828UNII IR84JPZ1RK
- Pharmacologic class
- Ergot Derivative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N451662166801followed by a unit qualifier and the quantityPackage 51662-1668-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Following delivery of the placenta, for routine management of uterine atony, hemorrhage and subinvolution of the uterus. For control of uterine hemorrhage in the second stage of labor following delivery of the anterior shoulder.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090193
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methylergonovine Maleate | Methylergonovine maleate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | American Regent, Inc. | 0517-0740 |